Capped antithrombin III dosing is cost effective in the management of asparaginase-associated thrombosis

被引:2
|
作者
Young, Jennifer [1 ]
Sawyer, Jaclyn [1 ]
Jenkins, Meredith [1 ]
O'Brien, Maureen [2 ,3 ]
Luchtman-Jones, Lori [3 ,4 ]
Breese, Erin H. [2 ,3 ]
机构
[1] Cincinnati Childrens Hosp Med Ctr, Div Pharm, 3333 Burnet Ave,MLC 15010, Cincinnati, OH 45209 USA
[2] Cincinnati Childrens Hosp Med Ctr, Div Oncol, Canc & Blood Dis Inst, Cincinnati, OH 45209 USA
[3] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA
[4] Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Div Hematol, Cincinnati, OH 45209 USA
关键词
antithrombin III; asparaginase-induced thrombosis; capped antithrombin III; ACUTE LYMPHOBLASTIC-LEUKEMIA; VENOUS THROMBOEMBOLISM; SUPPLEMENTATION;
D O I
10.1002/pbc.27719
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Asparaginase therapy induces a transient antithrombin III (ATIII) deficiency, which contributes to the risk of asparaginase-induced thrombosis. At Cincinnati Children's Hospital Medical Center, management of asparaginase-induced thrombosis includes ATIII supplementation during therapeutic anticoagulation with enoxaparin. Due to the expense associated with ATIII, a capped dosing approach for ATIII was evaluated in this population. Peak ATIII levels were obtained following capped doses to evaluate response. In this pilot evaluation, 11 patients received a total of 138 capped doses for a total cost savings of $803 782. This pilot evaluation represents the first reported analysis of capped ATIII dosing in oncology patients.
引用
收藏
页数:3
相关论文
共 39 条
  • [21] Low level of postoperative plasma antithrombin III is associated with portal vein thrombosis after liver surgery
    Masayuki Okuno
    Yusuke Kimura
    Kojiro Taura
    Nguyen Hai Nam
    Xuefeng Li
    Satoshi Ogiso
    Ken Fukumitsu
    Takamichi Ishii
    Satoru Seo
    Shinji Uemoto
    Surgery Today, 2021, 51 : 1343 - 1351
  • [22] Low level of postoperative plasma antithrombin III is associated with portal vein thrombosis after liver surgery
    Okuno, Masayuki
    Kimura, Yusuke
    Taura, Kojiro
    Nam, Nguyen Hai
    Li, Xuefeng
    Ogiso, Satoshi
    Fukumitsu, Ken
    Ishii, Takamichi
    Seo, Satoru
    Uemoto, Shinji
    SURGERY TODAY, 2021, 51 (08) : 1343 - 1351
  • [23] RECURRENT RENAL-VEIN THROMBOSIS AND RENAL-FAILURE ASSOCIATED WITH ANTITHROMBIN-III DEFICIENCY
    ELLIS, D
    PEDIATRIC NEPHROLOGY, 1992, 6 (02) : 131 - 134
  • [24] ANTITHROMBIN-III GLASGOW - A VARIANT WITH INCREASED HEPARIN AFFINITY AND REDUCED ABILITY TO INACTIVATE THROMBIN, ASSOCIATED WITH FAMILIAL THROMBOSIS
    LANE, DA
    LOWE, GDO
    FLYNN, A
    THOMPSON, E
    IRELAND, H
    ERDJUMENT, H
    BRITISH JOURNAL OF HAEMATOLOGY, 1987, 66 (04) : 523 - 527
  • [25] ANTITHROMBIN-III NAGASAKI (SER116-PRO) - A HETEROZYGOUS VARIANT WITH DEFECTIVE HEPARIN BINDING ASSOCIATED WITH THROMBOSIS
    OKAJIMA, K
    ABE, H
    MAEDA, S
    MOTOMURA, M
    TSUJIHATA, M
    NAGATAKI, S
    OKABE, H
    TAKATSUKI, K
    BLOOD, 1993, 81 (05) : 1300 - 1305
  • [26] ANTITHROMBIN-III GLASGOW - A VARIANT WITH INCREASED HEPARIN AFFINITY AND REDUCED ABILITY TO INACTIVATE THROMBIN, ASSOCIATED WITH FAMILIAL THROMBOSIS
    LANE, DA
    LOWE, GDO
    FLYNN, A
    IRELAND, H
    THOMPSON, E
    ERDJUMENT, H
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 427 - 427
  • [27] MODULATION OF HEMOSTATIC BALANCE WITH ANTITHROMBIN-III REPLACEMENT THERAPY IN A CASE OF LIVER-CIRRHOSIS ASSOCIATED WITH RECURRENT VENOUS THROMBOSIS
    CARMASSI, F
    MORALE, M
    DENEGRI, F
    CARRAI, M
    JOURNAL OF MOLECULAR MEDICINE-JMM, 1995, 73 (02): : 89 - 93
  • [28] THROMBOEMBOLIC COMPLICATIONS ASSOCIATED WITH L-ASPARAGINASE THERAPY - ETIOLOGIC ROLE OF LOW ANTITHROMBIN-III AND PLASMINOGEN LEVELS AND THERAPEUTIC CORRECTION BY FRESH-FROZEN PLASMA
    KUCUK, O
    KWAAN, HC
    GUNNAR, W
    VAZQUEZ, RM
    CANCER, 1985, 55 (04) : 702 - 706
  • [29] COST EFFECTIVE ANALYSIS OF PHARMACEUTICAL CARE IN MANAGEMENT OF PATIENTS WITH STAGE III HYPERTENSION: AN INDIAN PHARMACISTS EXPERIENCE
    Parimalakrishnan, S.
    Nachiya, Jainaf R.
    Smith, Anton A.
    Mohanta, G. P.
    Manna, P. K.
    VALUE IN HEALTH, 2017, 20 (09) : A916 - A916
  • [30] USE OF DOPPLER ENDOSCOPIC PROBE IS COST-EFFECTIVE FOR THE MANAGEMENT OF PEPTIC ULCER-ASSOCIATED HEMORRHAGE
    McCarty, Thomas R.
    Jirapinyo, Pichamol
    James, Lyndon
    Saltzman, John R.
    Jensen, Dennis M.
    Thompson, Christopher C.
    GASTROINTESTINAL ENDOSCOPY, 2020, 91 (06) : AB582 - AB583